HVC
PFE icon

Healthcare Value Capital’s Pfizer PFE Stock Holding History

Healthcare Value Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$2.15M Buy
+50,000
New +$2.22M 4.25% 13

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Healthcare Value Capital's PFE Position: Q3 2021 in Review

Healthcare Value Capital reduced its Pfizer (PFE) stake by 25% in Q3 2021, selling an estimated $1.11M and leaving 75,000 shares worth $3.23M. The position accounts for 6.37% of the portfolio, ranked #3.

Healthcare Value Capital first reported a position in PFE in Q1 2014 and has held it in 19 quarters since. The position peaked at $8.93M in Q3 2017. 2,803 funds tracked by Wall St. Rank hold PFE as of Q3 2021.

  • Healthcare Value Capital held 75,000 shares of Pfizer worth $3.23M as of Q3 2021.
  • Healthcare Value Capital sold 25,000 Pfizer shares in Q3 2021, an estimated $1.11M.
  • Pfizer made up 6.37% of Healthcare Value Capital's portfolio in Q3 2021, its #3 holding.
  • Healthcare Value Capital first reported a position in Pfizer in Q1 2014 and has held it in 19 quarters since.
  • Healthcare Value Capital's Pfizer position peaked at $8.93M in Q3 2017.
  • 2,803 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.

Based on Healthcare Value Capital's 13F filing for Q3 2021, filed 15 Nov 2021.